academic article

• Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers..  Parkinsonism & related disorders.  33-36. 2022
• Genome-wide association study and functional validation implicates JADE1 in tauopathy..  Acta neuropathologica.  143:33-53. 2021
• Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias..  Neurology.  96:e1855-e1864. 2021
• Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy..  Journal of neuropathology and experimental neurology.  80:102-111. 2021
• Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease..  Journal of Parkinson's disease.  11:737-745. 2021
• Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns..  Journal of neuropathology and experimental neurology.  79:1141-1146. 2020
• Tau pathology associates with in vivo cortical thinning in Lewy body disorders..  Annals of clinical and translational neurology.  7:2342-2355. 2020
• Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?.  Movement disorders : official journal of the Movement Disorder Society.  35:1618-1625. 2020
• Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study..  Nature communications.  11:-. 2020
• Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing..  Nature genetics.  51:1423-1424. 2019
• Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants..  Movement disorders clinical practice.  6:440-445. 2019
• Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing..  Nature genetics.  51:414-430. 2019
• The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease..  PloS one.  13:-. 2018
• APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease..  Movement disorders : official journal of the Movement Disorder Society.  33:289-297. 2017
• Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease..  Nature genetics.  49:1373-1384. 2017
• Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis..  Journal of Parkinson's disease.  7:385-395. 2017
• Statins and Cognition in Parkinson's Disease..  Journal of Parkinson's disease.  7:661-667. 2017
• The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease..  Parkinsonism & related disorders.  21-6. 2016
• Longitudinal study of normal cognition in Parkinson disease..  Neurology.  85:1276-82. 2015
• Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire..  Movement disorders : official journal of the Movement Disorder Society.  31:126-34. 2015
• Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects..  Brain : a journal of neurology.  138:2701-15. 2015
• Caregiver report of apathy predicts dementia in Parkinson's disease..  Parkinsonism & related disorders.  21:992-5. 2015
• Rarity of the Alzheimer disease-protective APP A673T variant in the United States..  JAMA neurology.  72:209-16. 2015
• Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study..  JAMA neurology.  71:1394-404. 2014
• Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias..  PLoS genetics.  10:-. 2014
• At the interface of sensory and motor dysfunctions and Alzheimer's disease..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  11:70-98. 2014
• A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases..  Journal of neuropathology and experimental neurology.  73:467-73. 2014
• Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers..  NeuroImage. Clinical.  164-73. 2013
• Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia..  Journal of Alzheimer's disease : JAD.  33:1089-95. 2013